Gen Nex Formulations Private Limited

Gen Nex Formulations Private Limited - trading in Rourkela, Odisha, India. FY 2026 financials & compliance.
CIN U24232OR2010PTC012803 Incorporated 14 December 2010 ROC Cuttack HQ Rourkela, Odisha, India
Active Private Limited Company trading
Revenue · FY 2025
₹11.76 Lakh
▼ 21% YoY
Net profit · FY 2025
₹3,133
Net margin 0.3%
EBITDA · FY 2025
₹4,430
EBITDA margin 0.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Gen Nex Formulations Private Limited

Data last updated:

Gen Nex Formulations Private Limited is a private limited company based in Rourkela, Odisha, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 14 December 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24232OR2010PTC012803. Its GSTIN is 10AAECG0475E1Z8 (Bihar).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sushil Kumar (Managing Director) and Bedraj Banktesh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 364/186/4 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.76 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹3,133 (net margin 0.3%) and EBITDA of ₹4,430 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 18% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232OR2010PTC012803
Registration Number 012803
Incorporation Date 14 December 2010
ROC Cuttack
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Gen Nex Formulations Private Limited's registered office is in Rourkela, Odisha. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. – 364/186/4 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Gen Nex Formulations Private Limited, buy the company report.

Comprehensive company report
Gen Nex Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gen Nex Formulations is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Gen Nex Formulations Private Limited, buy the company report.

Financials of Gen Nex Formulations Private Limited

FY 2025 filings available

Gen Nex Formulations Private Limited reported revenue of ₹11.76 Lakh (down 21% YoY) for FY 2025.

Revenue · FY 2025
₹11.76 Lakh ▼ 21%
Net profit · FY 2025
₹3,133 margin 0.3%
EBITDA · FY 2025
₹4,430 margin 0.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 23%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 31%
5 years · compounded
▼ 43%

Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 21% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4,430
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3,133
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.4%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gen Nex Formulations Private Limited, buy the company report.

Board of directors of Gen Nex Formulations Private Limited

Gen Nex Formulations has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sushil KumarManaging Director14 Dec 201015 Years 11 MonthsCurrent
Bedraj BankteshDirector14 Dec 201015 Years 11 MonthsCurrent

Peer comparison

Gen Nex Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pail Pharma Private Limited₹12 Lakh (FY 2024)Uttar Pradesh, India
Gen Nex Formulations Private Limitedthis company₹11.76 Lakh (FY 2025)₹3,1330.3%-21.0%Rourkela, Odisha, India
Corelife Pharma Private Limited₹11.56 Lakh (FY 2020)-26.0%Chennai, Tamil Nadu, India
Manfred Pharmaceuticals Private Limited₹11.51 Lakh (FY 2025)24.0%Kolhapur, Maharashtra, India

To see the full peer comparison of Gen Nex Formulations Private Limited, buy the company report.

Shareholding

The shareholding of Gen Nex Formulations Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gen Nex Formulations Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gen Nex Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gen Nex Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAECG0475E1Z8BiharActive01 Jul 2017

To see the full GST registrations and return filing status of Gen Nex Formulations Private Limited, buy the company report.

Recent activity

Gen Nex Formulations Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Bedraj Banktesh was appointed as Director on 14 Dec 2010.

AGM
Gen Nex Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gen Nex Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Appointed
Bedraj Banktesh was appointed as Director.
Appointed
Sushil Kumar was appointed as Managing Director.
Incorporation
14 Dec 2010
Gen Nex Formulations Private Limited was registered on 14 Dec 2010 with Roc Cuttack & aged 15 years 11 months as per MCA records.

Frequently asked questions

Gen Nex Formulations is an active private limited company based in Rourkela, Odisha, India. The company works in other wholesale, within the trading industry. It was incorporated on 14 December 2010 (16+ years old) and is registered under CIN U24232OR2010PTC012803.

Gen Nex Formulations has 2 current directors:

The latest financial statements of Gen Nex Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Gen Nex Formulations is 10AAECG0475E1Z8, registered in Bihar.

The CIN (Corporate Identification Number) of Gen Nex Formulations is U24232OR2010PTC012803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gen Nex Formulations was incorporated on 14 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Cuttack.

The peers of Gen Nex Formulations by revenue are Pail Pharma Private Limited, Corelife Pharma Private Limited, Manfred Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Bedraj Banktesh was appointed as Director on 14 Dec 2010. Sushil Kumar was appointed as Managing Director on 14 Dec 2010.

The registered office of Gen Nex Formulations is at Plot No. – 3641864 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009.

Gen Nex Formulations operates in the trading industry, in the other wholesale segment.

The compliance status of Gen Nex Formulations is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.